Skip to content
  • Sunday, 26 July 2026
  • 3:41 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Inflammatory Remodeling of the Bone Marrow Niche Drives Early Progression of Myelodysplastic Syndromes and Clonal Hematopoiesis
Stem Cell & Regenerative Medicine

Inflammatory Remodeling of the Bone Marrow Niche Drives Early Progression of Myelodysplastic Syndromes and Clonal Hematopoiesis

Dwi Wanna May 16, 2026 0

Every second of every day, the human bone marrow performs a silent biological miracle, generating millions of fresh blood and…

Read More
Stem Cell & Regenerative Medicine

Inflammatory Remodeling of the Bone Marrow Niche Drives Early Progression of Clonal Hematopoiesis and Myelodysplastic Syndromes

Dwi Wanna May 1, 2026 0

The human bone marrow is one of the most industrious organs in the body, serving as a biological factory that…

Read More
Stem Cell & Regenerative Medicine

Inflammatory Remodeling of the Bone Marrow Niche: New Insights into the Early Drivers of Myelodysplastic Syndromes and Clonal Hematopoiesis

Dwi Wanna Apr 16, 2026 0

The human bone marrow is one of the most industrious environments in the human body, functioning as a biological factory…

Read More
Stem Cell & Regenerative Medicine

Bone Marrow Microenvironment Remodeling Identified as Primary Driver in the Progression of Clonal Hematopoiesis and Myelodysplastic Syndromes

Dwi Wanna Apr 9, 2026 0

The human bone marrow functions as a biological factory of staggering proportions, generating millions of new blood and immune cells…

Read More
Seabird Guano: The Ancient Peruvian Fertilizer That Fueled a Kingdom’s RiseHow digital tools and AI are accelerating drug discoveryThe American Midlife Crisis: Why Middle-Aged Adults in the United States Are Falling Behind Their Global Peers in Health and Well-BeingImmunai’s Digital ‘Plumbing’ Keeps AstraZeneca Coming Back for Broader, Deeper Collaborations
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ